Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jan 15;32(1):346-53.
doi: 10.1093/nar/gkh187. Print 2004.

Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA

Affiliations
Comparative Study

Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA

Damian Ittig et al. Nucleic Acids Res. .

Abstract

The nuclear antisense properties of a series of tricyclo (tc)-DNA oligonucleotide 9-15mers, _targeted against the 3' and 5' splice sites of exon 4 of cyclophilin A (CyPA) pre-mRNA, were evaluated in HeLa cells and compared with those of corresponding LNA-oligonucleotides. While the 9mers showed no significant antisense effect, the 11-15mers induced exon 4 skipping and exon 3+4 double skipping to about an equal extent upon lipofectamine mediated transfection in a sequence- and dose-dependent manner, as revealed by a RT-PCR assay. The antisense efficacy of the tc-oligonucleotides was found to be superior to that of the LNA-oligonucleotides in all cases by a factor of at least 4-5. A tc-oligonucleotide 15mer completely abolished CyPA mRNA production at 0.2 microM concentration. The antisense effect was confirmed by western blot analysis which revealed a reduction in CyPA protein to 13% of its normal level. Fluorescence microscopic investigations with a fluorescein labeled tc-15mer revealed a strong propensity for homogeneous nuclear localization of this backbone type after lipofectamine mediated transfection, while the corresponding lna 15mer showed a less clear cellular distribution pattern. Transfection without lipid carrier showed no significant internalization of both tc- and LNA- oligonucleotides. The obtained results confirm the power of tc-DNA for nuclear antisense applications. Moreover, CyPA may become an interesting therapeutic _target due to its important role in the early steps of the viral replication of HIV-1.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Molecular structures of tc-DNA and LNA in comparison to DNA.
Figure 2
Figure 2
Schematic representation of the splicing pattern of CyPA pre-mRNA. The ball at tc6 or lna6 represents the fluorescein label.
Figure 3
Figure 3
RT–PCR analysis of CyPA pre-mRNA splicing in HeLa cells in the presence of varying concentrations (0.05, 0.1 and 0.2 µM) of antisense tc-oligonucleotides (lanes 1–12). Lane 13 (control): RNA from untreated cells.
Figure 4
Figure 4
Quantitative evaluation of full-length CyPA mRNA after treatment with tc-oligonucleotides. Values are normalized averages of two independent experiments. Control: RNA from untreated cells.
Figure 5
Figure 5
RT–PCR analysis of CyPA pre-mRNA splicing in HeLa cells in the presence of varying concentrations (0.05, 0.1 and 0.2 µM) of antisense lna-oligonucleotides (lanes 1–12). Lane 13 (control): RNA from untreated cells.
Figure 6
Figure 6
Quantitative evaluation of full-length CyPA mRNA after treatment with lna-oligonucleotides. All values are normalized averages with standard deviations from three independent experiments. Control: RNA from untreated cells.
Figure 7
Figure 7
Western blot, demonstrating the down-regulation of CyPA protein by tc4. CyPA protein was probed with polyclonal anti-CyPA antibodies. A polyclonal anti-actin antibody was used for loading control.
Figure 8
Figure 8
Fluorescence microscopic images of the cellular distribution of tc6 (left) and lna6 (right) in HeLa cells (top: phase contrast image; center: UV image; and bottom: overlay of both images).

Similar articles

Cited by

References

    1. Vacek M., Sazani,P. and Kole,R. (2003) Antisense-mediated redirection of mRNA splicing. Cell. Mol. Life Sci., 60, 825–833. - PMC - PubMed
    1. Kurreck J. (2003) Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem., 270, 1628–1644. - PubMed
    1. Friedman K.J., Kole,J., Cohn,J.A., Knowles,M.R., Silverman,L.M. and Kole,R. (1999) Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides. J. Biol. Chem., 274, 36193–36199. - PubMed
    1. Karras J.G., McKay,R.A., Dean,N.M. and Monia,B.P. (2000) Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing. Mol. Pharmacol., 58, 380–387. - PubMed
    1. Giles R.V., Spiller,D.G., Clark,R.E. and Tidd,D.M. (1999) Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA. Antisense Nucleic Acid Drug Dev., 9, 213–220. - PubMed

Publication types

MeSH terms

  NODES
ELIZA 3
Experiments 2
HOME 2
Interesting 1
Intern 1
Javascript 1
mac 1
os 15
text 12
twitter 2
web 4